It was also found that administration of evodiamine significantly decreased the levels of hepatic IL-1β, IL-6, and TNF-α in NASH rats, but did not significantly affect any of the three inflammatory factors in normal rats. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatohepatitis.